Les manifestations respiratoires de la mucoviscidose

Becker, 1996, Prevalence of ABPA and atopy in adult patients with cystic fibrosis, Chest, 109, 1536, 10.1378/chest.109.6.1536 Chemery, 2004, Capacité du transfert du monoxyde de carbone (TLCO) et saturation arterielle à l'exercice chez les patients atteints de mucoviscidose, Arch. Pediatr., 11, 1060, 10.1016/j.arcped.2004.04.019 Corey, 1997, Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis, J. Pediatr., 131, 809, 10.1016/S0022-3476(97)70025-8 Counil, 2007, Mucoviscidose: du bonusage des explorations fonctionnelles respiratoires, Rev. Mal. Respir., 24, 691, 10.1016/S0761-8425(07)91145-6 Drumm, 2005, Gene modifer study group, Genetic modifiers of lung disease in cystic fibrosis, N. Engl. J. Med., 353, 1443, 10.1056/NEJMoa051469 Fauroux, 2004, Setting of non-invasive pressure support in young patients with cystic fibrosis, Eur. Respir. J., 24, 624, 10.1183/09031936.04.0000137603 Flume, 2005, Pneumothorax in cystic fibrosis, Chest, 128, 720, 10.1378/chest.128.2.720 Flume, 2005, Massive hemoptysis in cystic fibrosis, Chest, 128, 729, 10.1378/chest.128.2.729 Gulmans, 1996, The six-minute walking test in children with cystic fibrosis: reliability and validity, Pediatr. Pulmonol, 22, 85, 10.1002/(SICI)1099-0496(199608)22:2<85::AID-PPUL1>3.0.CO;2-I Henry, 1992, Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis, Pediatr. Pulmonol, 12, 158, 10.1002/ppul.1950120306 Kerem, 1992, Prediction of mortality in patients with cystic fibrosis, N. Engl. J. Med, 326, 1187, 10.1056/NEJM199204303261804 Khan, 1995, Early pulmonary inflammation in infants with cystic fibrosis, Am. J. Respir. Crit. Care Meal, 151, 1075 Konstan, 2007, Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis, J. Pediatr, 151, 134, 10.1016/j.jpeds.2007.03.006 Lipuma, 2005, Update on the Burkholderia cepacia complex, Curr. Opin. Pulm. Med, 11, 528, 10.1097/01.mcp.0000181475.85187.ed Mastella, 2000, Allergic bronchopulmonary aspergillosis in cystic fibrosis, A European epidemiological study, Epidemiologic registery of cystic fibrosis, Eur. Respir. J, 16, 464, 10.1034/j.1399-3003.2000.016003464.x Nielsen, 2004, Serial lung function and responsiveness in cystic fibrosis during early childhood, Am. J. Respir. Crit. Care Med, 169, 1209, 10.1164/rccm.200303-347OC 2007, Rapport sur la situation de la mucoviscidose en France en 2005, Paris: Vaincre la mucoviscidose et Institut national d'études démographiques Puchelle, 2002, Airway mucus in cystic fibrosis, Paediatr. Respir. Rev, 3, 115, 10.1016/S1526-0550(02)00005-7 Ramsey, 1996, Management of pulmonary disease in patients with cystic fibrosis, N. Engl. J. Med, 335, 179, 10.1056/NEJM199607183350307 Rosenberg, 1992, Spirometry and chest roentgenographic appearance in adults with cystic fibrosis, Chest, 101, 961, 10.1378/chest.101.4.961 Selvadurai, 2003, Validation of shuttle tests in children with cystic fibrosis, Pediatr. Pulmonol, 35, 133, 10.1002/ppul.10197 Schidlow, 1993, Cystic fibrosis foundation consensus conference report on pulmonary complications of cystic fibrosis, Pediatr. Pulmonol, 15, 187, 10.1002/ppul.1950150311 Strausbaugh, 2007, Cystic fibrosis: a review of epidemiology and pathobiology, Clin. Chest Med, 28, 279, 10.1016/j.ccm.2007.02.011 Sturgess, 1982, Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants, Am. J. Pathol, 106, 303 Wang, 1984, Association of respiratory viral infections with pulmonarydeterioration in patients with cystic fibrosis, N. Engl. J. Med., 311, 1653, 10.1056/NEJM198412273112602